Monoclonal Antibodies and Antivirals against SARS-CoV-2 Reduce the Risk of Long COVID: A Retrospective Propensity Score-Matched Case-Control Study. - Cimellaro A; Addesi D; Cavallo M; Spagnolo F; Suraci E; Cordaro R; Spinelli I; Passafaro F; Colosimo M; Pintaudi M; Pintaudi C; On Behalf Of The CATAnzaro LOng Covid Cataloco Study Group (Biomedicines, 2022)